Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 453/02 (2006.01) A61K 31/439 (2006.01) A61P 25/28 (2006.01) C07D 209/00 (2006.01) C07D 487/08 (2006.01)

Patent

CA 2495685

The present invention relates to 1-aza-bicycloalkyl derivatives of formula (I), wherein X is CH2 or a single bond; Y is a group of formula (II, III, IV) and wherein R has the meanings as defined in the specification, which compounds are alpha 7 nicotinic acetylcholine receptor (nAChR) agonists; to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

L'invention concerne des dérivés de 1-aza-bicycloalkyle représentés par la formule (I), dans laquelle X représente CH¿2 ?ou une liaison unique ; Y représente un groupe représenté par la formule (II), (III) ou (IV) et R est tel que défini dans le descriptif. Les composés selon l'invention sont des agonistes du récepteur nicotinique de l'acétylcholine (nAChR) alpha-7. L'invention concerne également des procédés de production des composés selon l'invention, leur utilisation comme produits pharmaceutiques ainsi que des compositions pharmaceutiques contenant lesdits composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1513000

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.